Raymond James & Associates’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,455
Closed -$28K 4015
2022
Q1
$28K Sell
1,455
-292
-17% -$5.62K ﹤0.01% 3867
2021
Q4
$31K Sell
1,747
-1,863
-52% -$33.1K ﹤0.01% 3903
2021
Q3
$134K Sell
3,610
-6,536
-64% -$243K ﹤0.01% 3734
2021
Q2
$604K Sell
10,146
-351
-3% -$20.9K ﹤0.01% 2943
2021
Q1
$703K Buy
10,497
+197
+2% +$13.2K ﹤0.01% 2747
2020
Q4
$623K Sell
10,300
-486
-5% -$29.4K ﹤0.01% 2656
2020
Q3
$852K Sell
10,786
-247
-2% -$19.5K ﹤0.01% 2269
2020
Q2
$690K Sell
11,033
-2
-0% -$125 ﹤0.01% 2380
2020
Q1
$585K Buy
11,035
+1,843
+20% +$97.7K ﹤0.01% 2307
2019
Q4
$1.11M Sell
9,192
-3,977
-30% -$481K ﹤0.01% 2209
2019
Q3
$2.39M Sell
13,169
-207
-2% -$37.6K ﹤0.01% 1668
2019
Q2
$1.74M Sell
13,376
-1,233
-8% -$160K ﹤0.01% 1878
2019
Q1
$3.56M Buy
14,609
+652
+5% +$159K 0.01% 1391
2018
Q4
$2.66M Sell
13,957
-1,209
-8% -$230K ﹤0.01% 1470
2018
Q3
$4.97M Buy
15,166
+775
+5% +$254K 0.01% 1221
2018
Q2
$4.49M Buy
14,391
+3,326
+30% +$1.04M 0.01% 1257
2018
Q1
$2.69M Buy
11,065
+654
+6% +$159K ﹤0.01% 1507
2017
Q4
$3.14M Buy
10,411
+2,620
+34% +$791K 0.01% 1399
2017
Q3
$2.06M Buy
7,791
+513
+7% +$136K ﹤0.01% 1626
2017
Q2
$1.92M Buy
7,278
+1,615
+29% +$426K ﹤0.01% 1600
2017
Q1
$2.04M Buy
5,663
+648
+13% +$233K ﹤0.01% 1516
2016
Q4
$1.45M Sell
5,015
-204
-4% -$58.9K ﹤0.01% 1707
2016
Q3
$1.78M Buy
5,219
+1,595
+44% +$543K ﹤0.01% 1531
2016
Q2
$1.54M Buy
3,624
+3,072
+557% +$1.31M ﹤0.01% 1479
2016
Q1
$177K Buy
552
+40
+8% +$12.8K ﹤0.01% 2594
2015
Q4
$265K Buy
+512
New +$265K ﹤0.01% 2236
2015
Q3
Sell
-758
Closed -$298K 2376
2015
Q2
$298K Buy
758
+43
+6% +$16.9K ﹤0.01% 2275
2015
Q1
$216K Buy
+715
New +$216K ﹤0.01% 2296